By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Synageva BioPharma 

Corporate Offices
128 Spring Street, Suite 520
Lexington  Massachusetts  02421  U.S.A.
Phone: 781-890-1111 Fax: 781-890-1114


Synageva BioPharma is a clinical stage biopharmaceutical company focused on the discovery, development, and commercialization of therapeutic products for patients with life-threatening rare diseases and unmet medical need. Our lead program, SBC-102, an enzyme replacement therapy for LAL Deficiency, is currently being evaluated in global Phase I/II clinical trials. SBC-102 has been granted orphan designations by the U.S. Food and Drug Administration (“FDA”) and the European Medicines Agency and fast track designation by the FDA. Synageva has several protein therapeutics focused on life threatening conditions in its pipeline. The Company has assembled a team with a proven record of bringing orphan therapies to patients.

Key Statistics

Ownership: Public

Web Site: Synageva BioPharma
Symbol: GEVA

Company News
Alexion (ALXN) Accepts Shares Of Synageva BioPharma (GEVA) Tendered Into Exchange Offer 6/22/2015 3:46:41 PM
Synageva BioPharma (GEVA) Completes Targeted Enrollment In Phase 1/2 Trial With SBC-103 For Mucopolysaccharidosis IIIB 6/5/2015 6:27:21 AM
Alexion (ALXN) And Synageva BioPharma (GEVA) Announce Early Termination Of Hart-Scott-Rodino Waiting Period For Alexion’s Pending Acquisition Of Synageva 6/1/2015 2:22:53 PM
Synageva BioPharma (GEVA) Submits Kanuma (Sebelipase Alfa) Application For LAL Deficiency In Japan 5/27/2015 6:38:05 AM
Alexion (ALXN) Plunks Down $8.4 Billion for Synageva BioPharma (GEVA), As Dealmaking Roars 5/6/2015 5:50:36 AM
Synageva BioPharma (GEVA) Reports First Quarter 2015 Financial Results and Provides General Business Updates 4/29/2015 12:25:18 PM
Synageva BioPharma (GEVA) Submits Kanuma (Sebelipase Alfa) Application For LAL Deficiency In Mexico 3/30/2015 11:58:02 AM
1,075 New Jobs to be Added by 11 Life Science Firms in Massachusetts: Amgen (AMGN), Alnylam (ALNY), Biogen Idec, Inc. (North Carolina) (BIIB), GE Healthcare Bio-Sciences, Quest Diagnostics (DGX), Alkermes (ALKS), Baxter Healthcare (BAX), Merrimack (MACK), Synageva BioPharma (GEVA), Philips Electronics, SMC 3/19/2015 6:51:59 AM
Synageva BioPharma (GEVA) Joins NORD, EURORDIS, And The Global Genes Project In Support Of Rare Disease Day 2015 2/27/2015 10:29:19 AM
Synageva BioPharma (GEVA) Reports 2014 Full Year Financial Results 2/27/2015 7:20:13 AM